Exelixis (EXEL): are the analysts right?

Exelixis · Health Care · ref. ETF XLV · 68 calls · price $55.39
What the company does: Exelixis Inc., société d'oncologie, découvre, développe et commercialise des médicaments pour les cancers difficiles à traiter.
📈 1-year price
$57.08+31.2% over range
Jul 8, 25low $34.54 · high $57.08Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 9 analysts
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 Analyst price target on EXEL

High target · 3 analysts$56+1.1%
Median target · 9 analysts$50-9.7%
Low target · 1 analyst$40-27.8%
Current price$55.39

🗳️ The analyst consensus

Analyst breakdown · 9 (6 months)
Strong Buy0%
Buy33%
Hold67%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on EXEL

Most reliable analysts on EXEL (% profitable · 365j · ≥2 calls)
Guggenheim 100% +26.5% 7
HC Wainwright & Co. 75% +21.3% 12

📊 What $1,000 invested in Exelixis would be worth

In short — $1,000 invested in Exelixis 10 years ago would be worth $9,647 today, i.e. +25%/yr on average. Best year: 2016 (+164%), worst: 2018 (-35%). Price performance, excluding dividends.

If I'd invested $1,000 in Exelixis

InvestmentWorth todayGain
1 years ago$1,634+63%
3 years ago$3,392+239%
5 years ago$2,711+171%
10 years ago$9,647+865%
since inception (2000)$2,244+124%

Return by year (Exelixis)

YearReturn$1,000 invested at year start
2026 (YTD)+24%$1,241 (+24%)
2025+32%$1,634 (+63%)
2024+39%$2,268 (+127%)
2023+50%$3,392 (+239%)
2022-12%$2,976 (+198%)
2021-9%$2,711 (+171%)
2020+14%$3,088 (+209%)
2019-10%$2,766 (+177%)
2018-35%$1,790 (+79%)
2017+104%$3,649 (+265%)
2016+164%$9,647 (+865%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on EXEL

■ Hold neutral · not a buy · 🎯$54
Price at call : $54.77 — gap to target -1%
Today : $55.39 — gap to target -3%
🎯 on EXEL : 100% (1 call matured) · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Jun 25, 27
Citizens
Jun 24, 26
▲ Market Outperform · 🎯$55
Price at call : $52.87 — upside +4%
Today : $55.39 — upside -1%
🎯 on EXEL : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jun 24, 27
▲ Buy · 🎯$56
Price at call : $46.21 — upside +21%
Today : $55.39 — upside +1%
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : May 7, 27
TD Cowen
May 6, 26
▲ Buy · 🎯$55
Price at call : $46.21 — upside +19%
Today : $55.39 — upside -1%
🎯 on EXEL : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : May 6, 27
■ Equal-Weight neutral · not a buy · 🎯$50
Price at call : $46.21 — gap to target +8%
Today : $55.39 — gap to target -10%
🎯 on EXEL : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : May 6, 27
Stifel
May 6, 26
■ Hold neutral · not a buy · 🎯$47
Price at call : $46.21 — gap to target +2%
Today : $55.39 — gap to target -15%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : May 6, 27
Wells Fargo
May 6, 26
■ Equal-Weight neutral · not a buy · 🎯$40
Price at call : $46.21 — gap to target -13%
Today : $55.39 — gap to target -28%
🎯 on EXEL : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : May 6, 27
Barclays
Apr 20, 26
■ Equal-Weight neutral · not a buy · 🎯$45
Price at call : $45.89 — gap to target -2%
Today : $55.39 — gap to target -19%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Apr 20, 27
RBC Capital
Mar 2, 26
■ Sector Perform neutral · not a buy · 🎯$43
Price at call : $40.74 — gap to target +6%
Today : $55.39 — gap to target -22%
🎯 on EXEL : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Mar 2, 27
▲ Buy · 🎯$54
Price at call : $42.7 — upside +26%
Today : $55.39 — upside -3%
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Feb 12, 27
RBC Capital
Feb 11, 26
■ Sector Perform neutral · not a buy · 🎯$46
Price at call : $42.7 — gap to target +8%
Today : $55.39 — gap to target -17%
🎯 on EXEL : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Feb 11, 27
Stifel
Feb 11, 26
■ Hold neutral · not a buy · 🎯$44
Price at call : $42.7 — gap to target +3%
Today : $55.39 — gap to target -21%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Feb 11, 27
Wells Fargo
Feb 11, 26
■ Equal-Weight neutral · not a buy · 🎯$35
Price at call : $42.7 — gap to target -18%
Today : $55.39 — gap to target -37%
🎯 on EXEL : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 11, 27
Barclays
Feb 4, 26
■ Equal-Weight neutral · not a buy · 🎯$44
Price at call : $42.65 — gap to target +3%
Today : $55.39 — gap to target -21%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Feb 4, 27
▲ Buy · 🎯$52
Price at call : $42.59 — upside +22%
Today : $55.39 — upside -6%
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Feb 3, 27
■ Equal-Weight neutral · not a buy · 🎯$49
Price at call : $42.59 — gap to target +15%
Today : $55.39 — gap to target -12%
🎯 on EXEL : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Feb 2, 27
▲ Buy · 🎯$52
Price at call : $43.74 — upside +19%
Today : $55.39 — upside -6%
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Jan 27, 27
▲ Buy · 🎯$52
Price at call : $44.04 — upside +18%
Today : $55.39 — upside -6%
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Jan 8, 27
■ Equal-Weight neutral · not a buy · 🎯$48
Price at call : $44.15 — gap to target +9%
Today : $55.39 — gap to target -13%
🎯 on EXEL : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Jan 8, 27
UBS
Nov 6, 25
■ Neutral neutral · not a buy · 🎯$40
Price at call : $40.81 — gap to target -2%
Today : $55.39 — gap to target -28%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Nov 6, 26
TD Cowen
Nov 5, 25
▲ Buy · 🎯$51
Price at call : $40.8 — upside +25%
Today : $55.39 — upside -8%
🎯 on EXEL : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Nov 5, 26
▲ Overweight · 🎯$45
Price at call : $40.8 — upside +10%
Today : $55.39 — upside -19%
🎯 on EXEL : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Nov 5, 26
Barclays
Nov 5, 25
■ Equal-Weight neutral · not a buy · 🎯$41
Price at call : $40.8 — gap to target +0%
Today : $55.39 — gap to target -26%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Nov 5, 26
▲ Buy · 🎯$49
Price at call : $40.8 — upside +20%
Today : $55.39 — upside -12%
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Nov 5, 26
Guggenheim
Nov 3, 25
■ Neutral neutral · not a buy
🎯 on EXEL : 100% (7 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Nov 3, 26
▲ Overweight · 🎯$44
Price at call : $36.08 — upside +22%
Today : $55.39 — upside -21%
🎯 on EXEL : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Oct 21, 26
RBC Capital
Oct 21, 25
■ Sector Perform neutral · not a buy · 🎯$45
Price at call : $36.08 — gap to target +25%
Today : $55.39 — gap to target -19%
🎯 on EXEL : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Oct 21, 26
Wells Fargo
Oct 21, 25
■ Equal-Weight neutral · not a buy · 🎯$30
Price at call : $36.13 — gap to target -17%
Today : $55.39 — gap to target -46%
🎯 on EXEL : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Oct 21, 26
▲ Outperform · 🎯$48
Price at call : $36.13 — upside +33%
Today : $55.39 — upside -13%
🎯 on EXEL : no call matured yet · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Oct 21, 26
▲ Overweight · 🎯$50
Price at call : $40.45 — upside +24%
Today : $55.39 — upside -10%
🎯 on EXEL : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Sep 17, 26
Goldman Sachs
Sep 17, 25
▲ Buy · 🎯$47
Price at call : $40.45 — upside +16%
Today : $55.39 — upside -15%
🎯 on EXEL : no call matured yet · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Sep 17, 26
Barclays
Sep 17, 25
■ Equal-Weight neutral · not a buy · 🎯$40
Price at call : $40.44 — gap to target -1%
Today : $55.39 — gap to target -28%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Sep 17, 26
▲ Buy · 🎯$46
Price at call : $37.95 — upside +21%
Today : $55.39 — upside -17%
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Aug 12, 26
UBS
Jul 30, 25
■ Neutral neutral · not a buy · 🎯$38
Price at call : $36.22 — gap to target +5%
Today : $55.39 — gap to target -31%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Jul 30, 26
▲ Buy · 🎯$49
Price at call : $36.85 — upside +33%
Today : $55.39 — upside -12%
🎯 on EXEL : 100% (1 call matured) · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Jul 29, 26
▲ Overweight · 🎯$46
Price at call : $36.85 — upside +25%
Today : $55.39 — upside -17%
🎯 on EXEL : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Jul 29, 26
RBC Capital
Jul 29, 25
■ Sector Perform neutral · not a buy · 🎯$45
Price at call : $36.85 — gap to target +22%
Today : $55.39 — gap to target -19%
🎯 on EXEL : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Jul 29, 26
JMP Securities
Jul 29, 25
▲ Market Outperform · 🎯$50
Price at call : $36.85 — upside +36%
Today : $55.39 — upside -10%
🎯 on EXEL : 100% (1 call matured) · 📊 unranked overall
in progress (365j)
matures : Jul 29, 26
Guggenheim
Jul 29, 25
▲ Buy · 🎯$45
Price at call : $36.85 — upside +22%
Today : $55.39 — upside -19%
🎯 on EXEL : 100% (7 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Jul 29, 26
Stifel
Jul 29, 25
■ Hold neutral · not a buy · 🎯$41
Price at call : $36.94 — gap to target +11%
Today : $55.39 — gap to target -26%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Jul 29, 26
▲ Overweight · 🎯$48
Price at call : $44.47 — upside +8%
Today : $55.39 — upside -13%
🎯 on EXEL : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Jul 22, 26
▲ Buy · 🎯$56
Price at call : $44.81 — upside +25%
Today : $55.39 — upside +1%
🎯 on EXEL : 100% (1 call matured) · 📊 on Health : 62% · +8.5% (92 calls)
in progress (365j)
matures : Jul 15, 26
UBS
Jul 11, 25
■ Neutral neutral · not a buy · 🎯$43
Price at call : $45.58 — gap to target -6%
Today : $55.39 — gap to target -22%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Jul 11, 26
Barclays
Jul 10, 25
■ Equal-Weight neutral · not a buy · 🎯$40
Price at call : $44.86 — gap to target -11%
Today : $55.39 — gap to target -28%
🎯 on EXEL : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Jul 10, 26
RBC Capital
Jul 8, 25
■ Sector Perform neutral · not a buy · 🎯$50
Price at call : $44.07 — gap to target +13%
Today : $55.39 — gap to target -10%
🎯 on EXEL : no call matured yet · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Jul 8, 26
▲ Buy · 🎯$53
Price at call : $44.08 — upside +20%
Today : $55.39 — upside -4%
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Jun 30, 26
▲ Overweight · 🎯$60
Price at call : $45.72 — upside +31%
Today : $55.39 — upside +8%
Expected +31% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 100% (1 call matured) · 📊 on Health : 62.2% · +10.1% (37 calls)
+15.6%
stock +16% · XLV +15%
▲ Buy · 🎯$55
Price at call : $45.72 — upside +20%
Today : $55.39 — upside -1%
Expected +20% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 100% (1 call matured) · 📊 on Health : 62% · +8.5% (92 calls)
+15.6%
stock +16% · XLV +15%
JMP Securities
Jun 23, 25
▲ Market Outperform · 🎯$50
Price at call : $43.37 — upside +15%
Today : $55.39 — upside -10%
Expected +15% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 100% (1 call matured) · 📊 unranked overall
+18.4%
stock +18% · XLV +15%
▲ Buy · 🎯$47
Price at call : $41.78 — upside +12%
Today : $55.39 — upside -15%
Expected +12% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+27.2%
stock +27% · XLV +12%
▲ Buy · 🎯$40
Price at call : $36.84 — upside +9%
Today : $55.39 — upside -28%
Expected +9% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+12.7%
stock +13% · XLV -1%
▲ Buy · 🎯$40
Price at call : $34.49 — upside +16%
Today : $55.39 — upside -28%
Expected +16% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+27.3%
stock +27% · XLV +8%
▲ Buy · 🎯$40
Price at call : $34.49 — upside +16%
Today : $55.39 — upside -28%
Expected +16% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+27.3%
stock +27% · XLV +8%
Guggenheim
Feb 12, 25
▲ Buy · 🎯$42
Price at call : $34.49 — upside +22%
Today : $55.39 — upside -24%
Expected +22% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 100% (7 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
+27.3%
stock +27% · XLV +8%
▲ Buy · 🎯$40
Price at call : $32.73 — upside +22%
Today : $55.39 — upside -28%
Expected +22% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+33.6%
stock +34% · XLV +5%
Guggenheim
Jan 22, 25
▲ Buy
Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 100% (7 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
+29.7%
stock +30% · XLV +9%
▲ Buy · 🎯$40
Price at call : $36.02 — upside +11%
Today : $55.39 — upside -28%
Expected +11% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+22.3%
stock +22% · XLV +13%
Guggenheim
Jan 7, 25
▲ Buy · 🎯$42
Price at call : $34.5 — upside +22%
Today : $55.39 — upside -24%
Expected +22% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 100% (7 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
+28.0%
stock +28% · XLV +13%
Guggenheim
Oct 30, 24
▲ Buy · 🎯$33
Price at call : $33.2 — upside -1%
Today : $55.39 — upside -40%
Expected -1% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 100% (7 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
+16.5%
stock +16% · XLV -2%
▲ Buy · 🎯$29
Price at call : $26.82 — upside +8%
Today : $55.39 — upside -48%
Expected +8% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on EXEL : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+50.8%
stock +51% · XLV -12%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)